Dr. Landgren from the Sylvester Comprehensive Cancer Center discusses the current gaps in Myeloma research and treatment, including the need for precision medicine, redefining highrisk disease, and using bloodbased technologies for disease tracking and treatment decisionmaking. He also highlights the importance of immunotherapies, including the use of genetic code to synthesize antibodies in the human body.

The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at https://www.healthtree.org/myeloma/co...

Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: https://give.healthtree.org/campaign/...

HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/

Follow HealthTree:
twitter.com/healthtreeformm
facebook.com/healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma